Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03402334 · ClinicalTrials.gov registry record · NA
Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors
A NA study, sponsored by Tulane University.
- Completed
- Registry status
- NA
- Development phase
- 231
- Enrollment target
NCT03402334 is a NA study that has completed, run by Tulane University. The registered enrollment target is 231 participants.
The verdict
NCT03402334, a NA study, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
Study Summary
The study aims to compare the effect of a cardiovascular education package intervention on treatment-seeking behavioral outcomes of HCV+ patients. This prospective multicenter trial will compare outcomes between the intervention group (HCV+ patients receiving the enhanced education package) and the control group (HCV+ patients receiving the standard of care, the basic education package). The primary outcome measured will be successful linkage to hepatology for a discussion of HCV treatment options. The secondary outcome measured will be linkage to primary care for chronic disease management.
Interventions
- BEHAVIORAL Patient counseling for HCV associated CVD risk factors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2019-03-11 |
| Est. Completion | 2021-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03402334
The ClinicalTrials.gov registry entry for NCT03402334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patient counseling for HCV associated CVD risk factors is the first listed.
NCT03402334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03402334 about?
NCT03402334 is a clinical study titled "Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors". The study aims to compare the effect of a cardiovascular education package intervention on treatment-seeking behavioral outcomes of HCV+ patients. This prospective multicenter trial will compare outcomes between the intervention group (HCV+ patients receiving the enhanced education package) and the ...
What is the current status of trial NCT03402334?
This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2019-03-11. Estimated completion is 2021-04-30.
What interventions are being tested in trial NCT03402334?
The interventions under investigation include: Patient counseling for HCV associated CVD risk factors (BEHAVIORAL).
Who is sponsoring clinical trial NCT03402334?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.